Home > Endocrinology > EASD 2020 > EASD 2020 Highlights Podcast

EASD 2020 Highlights Podcast

Presented by
Dr Rachel Giles, Medicom
EASD 2020


Dr Rachel Giles guides us through 6 abstracts from the 56th EASD Annual Meeting:

  1. Ertugliflozin offers some kidney protection - Cherney et al.
  2. Empagliflozin significantly reduces CV and renal risk - Packer et al.
  3. Once daily oral treatment with glucokinase activator TTP399 reduced HbA1c in patients with type 1 diabetes - Valcarce et al.
  4. Diabetes still goes unnoticed, resulting in delayed diagnosis - Young et al.
  5. Once-weekly insulin is a promising treatment option - Rosenstock et al.
  6. Intermittent fasting: consuming fewer calories but in a different way - Varady et al.

Posted on